Navigation Links
Mr. James Mellon and Dr. Gregory Bailey ("Offerors") Announce Additional Shares in Portage Biotech Inc. (Portage)
Date:12/14/2015

TORONTO, Dec. 14, 2015 /PRNewswire/ - The Offerors, announced that they have acquired an aggregate of 494,000 common shares of Portage. These common shares represent approximately 0.2% of the issued and outstanding common shares of Portage (based upon the 245,438,894 common shares stated to be issued and outstanding as at November 24, 2015, by Portage in its management's discussion and analysis for the three months ended September 30, 2015 (the "Q2 MD&A") filed on SEDAR on November 26, 2015. These common shares were purchased by the Offerors through the facilities of the OTC Markets and CSE for an average price of $0.13 (US$0.098) per share.

After giving effect to the purchases described in Section (2) above, Offerors now have ownership and control over 85,078,042 common shares of Portage, representing approximately 34.66% of the outstanding common shares of Portage (based upon 245,438,894 common shares stated to be issued and outstanding as at November 24, 2015 by Portage in the Q2 MD&A). After giving effect to the purchases noted above, Offerors, together with another joint actor, Dr. Declan Doogan, now have ownership and control over 113,389,110 common shares of Portage, representing approximately 46.20% of the outstanding common shares of Portage (based upon 245,438,894 common shares stated to be issued and outstanding as at November 24, 2015 by Portage in the Q2 MD&A).

The Offerors hold the common shares of Portage noted above for investment purposes. The Offerors may, from time to time on an individual or joint basis in the future, directly or indirectly acquire ownership of or control over additional securities of Portage. Dr. Declan Doogan, CEO and a director of Portage, who may be considered to be acting jointly or in concert with the Offerors, may, from time to time on an individual or joint basis in the future, directly or indirectly acquire ownership of or control over common shares of Portage. 

The 494,000 common shares the Offerors acquired pursuant to the purchases noted above were acquired in reliance upon the normal course purchase exemption from the take-over bid requirements provided by section 100 of the Securities Act (Ontario) and section 4.1 of Multilateral Instrument 62-104 ─ Take-Over Bids and Issuer Bids. Such 494,000 common shares represent less than 1% of the 245,438,894 common shares outstanding, and the Offerors together with Dr. Doogan acting jointly or in concert with the Offerors acquired 3.6 million common shares of Portage within the 12-month period preceding the share purchases noted above or the date of this press release. There is a published market for the common shares of Portage, and none of the 494,000 common shares that are the subject of this press release were acquired for consideration with a value in excess of the market price of the common shares on the date of the purchases noted above, plus reasonable brokerage fees or commissions actually paid.

An early warning report in connection with this press release is being filed by the Offerors in accordance with applicable Canadian securities laws and will be available on the SEDAR website at www.sedar.com.


'/>"/>
SOURCE Portage Biotech Inc.
Copyright©2015 PR Newswire.
All rights reserved


Related biology technology :

1. Novogen Appoints Dr James Garner as Chief Executive Officer
2. AnaptysBio Announces Appointment Of James A. Schoeneck To Board Of Directors
3. Oncimmune Appoints Dr James Jett, World Recognised Lung Cancer Specialist, as Chief Medical Officer
4. Immune Pharmaceuticals to Present at Dawson James Growth Stock Conference
5. TapImmune to Present at Dawson James Small Cap Growth Conference in Florida on October 15, 2015
6. RXi Pharmaceuticals to Present at Dawson James Securities Growth Stock Conference
7. Vault Nano Inc. Announces Dr. James Mulé and Dr. Antoni Ribas to Join Scientific Advisory Board
8. Carlyle Conlan and George James Ltd Release the 2015 Life Science Trends White Paper
9. James Earl Jones hosts new "In America" feature on Botany
10. Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board
11. Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2020)... , ... August 03, 2020 , ... Introducing Ardent Animal ... transformative growth, , Known as MediVet Biologics since its formation ... The new Ardent Animal Health will build on its base of innovative ...
(Date:7/31/2020)... Texas (PRWEB) , ... July 29, 2020 , ... ... solutions today announced the launch of its new tagline, “BUILDING FOR LIFE.” The ... biopharmaceutical industry and around the globe, requiring fast track capacity to provide patients ...
(Date:7/31/2020)... ... July 29, 2020 , ... Anomet ... to three different materials for use with CRM, neurostimulation, vascular, and related devices. ... to meet specific design requirements, performance, and cost criteria; especially where solid wire ...
(Date:7/31/2020)... ... 2020 , ... eSource has long been touted as the solution to high ... eSource, the reasons it did not take off as quickly as people initially expected, ... is moving towards capturing data electronically for clinical trials and then repurposing it for ...
Breaking Biology Technology:
(Date:8/23/2020)... ... August 21, 2020 , ... The August edition of ... now available on the company’s global website. Crystallography Times—an electronic newsletter published by ... news and crystallographic research. , The latest issue of Crystallography Times introduces ...
(Date:8/21/2020)... (PRWEB) , ... August 20, 2020 , ... ... that Hassan Movahhed , a Clinical Operations executive with expertise in clinical ... has joined the firm as an Expert Consultant. Throughout his career, Mr. Movahhed ...
(Date:8/7/2020)... ... August 06, 2020 , ... Nine middle ... National STEM Scholar Program, a unique professional development program that provides advanced STEM ... middle school science teachers nationwide. , Created in partnership between the National Stem ...
Breaking Biology News(10 mins):